Biofrontera Warrants Profit Margin vs. Revenue

BFRIW Stock  USD 0.13  0.05  64.77%   
Based on Biofrontera Warrants' profitability indicators, Biofrontera Warrants may not be well positioned to generate adequate gross income at this time. It has a very high odds of underperforming in December. Profitability indicators assess Biofrontera Warrants' ability to earn profits and add value for shareholders.

Biofrontera Warrants Net Profit Margin

(0.62)

Price To Sales Ratio is likely to drop to 0.12 in 2024. Days Sales Outstanding is likely to drop to 53.97 in 2024. Net Interest Income is likely to drop to about (305.6 K) in 2024. Interest Income is likely to drop to about 90.6 K in 2024.
Current ValueLast YearChange From Last Year 10 Year Trend
Gross Profit Margin0.540.488
Significantly Up
Slightly volatile
For Biofrontera Warrants profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Biofrontera Warrants to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Biofrontera Warrants utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Biofrontera Warrants's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Biofrontera Warrants over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
For more information on how to buy Biofrontera Stock please use our How to Invest in Biofrontera Warrants guide.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Biofrontera Warrants. If investors know Biofrontera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Biofrontera Warrants listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.30)
Revenue Per Share
11.573
Quarterly Revenue Growth
0.34
Return On Assets
(0.40)
Return On Equity
(1.49)
The market value of Biofrontera Warrants is measured differently than its book value, which is the value of Biofrontera that is recorded on the company's balance sheet. Investors also form their own opinion of Biofrontera Warrants' value that differs from its market value or its book value, called intrinsic value, which is Biofrontera Warrants' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Biofrontera Warrants' market value can be influenced by many factors that don't directly affect Biofrontera Warrants' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Biofrontera Warrants' value and its price as these two are different measures arrived at by different means. Investors typically determine if Biofrontera Warrants is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Biofrontera Warrants' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Biofrontera Warrants Revenue vs. Profit Margin Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Biofrontera Warrants's current stock value. Our valuation model uses many indicators to compare Biofrontera Warrants value to that of its competitors to determine the firm's financial worth.
Biofrontera Warrants is rated second in profit margin category among its peers. It is the top company in revenue category among its peers . At this time, Biofrontera Warrants' Net Loss is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Biofrontera Warrants by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Biofrontera Revenue vs. Profit Margin

Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.

Biofrontera Warrants

Profit Margin

 = 

Net Income

Revenue

X

100

 = 
(0.38) %
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Biofrontera Warrants

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
34.07 M
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Biofrontera Revenue vs Competition

Biofrontera Warrants is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 43.64 Million. Biofrontera Warrants totals roughly 34.07 Million in revenue claiming about 78% of equities under Health Care industry.

Biofrontera Warrants Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Biofrontera Warrants, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Biofrontera Warrants will eventually generate negative long term returns. The profitability progress is the general direction of Biofrontera Warrants' change in net profit over the period of time. It can combine multiple indicators of Biofrontera Warrants, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Last ReportedProjected for Next Year
Net Interest Income-291 K-305.6 K
Interest Income168 K90.6 K
Operating Income-22.7 M-23.8 M
Net Loss-26.4 M-27.8 M
Income Before Tax-20.1 M-21.1 M
Total Other Income Expense Net2.6 M2.1 M
Net Loss-20.1 M-21.1 M
Income Tax Expense14 K13.3 K
Net Loss(13.02)(13.67)
Income Quality 1.24  1.17 
Net Income Per E B T 1.00  0.81 

Biofrontera Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Biofrontera Warrants. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Biofrontera Warrants position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Biofrontera Warrants' important profitability drivers and their relationship over time.

Use Biofrontera Warrants in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Biofrontera Warrants position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biofrontera Warrants will appreciate offsetting losses from the drop in the long position's value.

Biofrontera Warrants Pair Trading

Biofrontera Warrants Pair Trading Analysis

The ability to find closely correlated positions to Biofrontera Warrants could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Biofrontera Warrants when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Biofrontera Warrants - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Biofrontera Warrants to buy it.
The correlation of Biofrontera Warrants is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Biofrontera Warrants moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Biofrontera Warrants moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Biofrontera Warrants can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Biofrontera Warrants position

In addition to having Biofrontera Warrants in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Consumption Thematic Idea Now

Consumption
Consumption Theme
Companies that deliver final goods such as cars or clothing for consumption by consumers. The Consumption theme has 19 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Consumption Theme or any other thematic opportunities.
View All  Next Launch

Additional Tools for Biofrontera Stock Analysis

When running Biofrontera Warrants' price analysis, check to measure Biofrontera Warrants' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biofrontera Warrants is operating at the current time. Most of Biofrontera Warrants' value examination focuses on studying past and present price action to predict the probability of Biofrontera Warrants' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biofrontera Warrants' price. Additionally, you may evaluate how the addition of Biofrontera Warrants to your portfolios can decrease your overall portfolio volatility.